SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-070199
Filing Date
2019-12-05
Accepted
2019-12-05 16:08:12
Documents
8
Period of Report
2019-12-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1924245-3_8k.htm 8-K 25893
2 EXHIBIT 1.1 tm1924245d3_ex1-1.htm EX-1.1 185086
3 EXHIBIT 5.1 tm1924245d3_ex5-1.htm EX-5.1 8734
4 EXHIBIT 99.1 tm1924245d3_ex99-1.htm EX-99.1 11229
5 EXHIBIT 99.2 tm1924245d3_ex99-2.htm EX-99.2 11613
6 GRAPHIC tm1924245d3_ex5-1img001.jpg GRAPHIC 8960
7 GRAPHIC tm1924245d3_ex99-1img001.jpg GRAPHIC 4245
8 GRAPHIC tm1924245d3_ex99-2img001.jpg GRAPHIC 8549
  Complete submission text file 0001104659-19-070199.txt   274262
Mailing Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104
Business Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35890 | Film No.: 191270510
SIC: 2834 Pharmaceutical Preparations